Paper25758928
Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.
Schulte B and 5 others. Int J Prison Health, 2009. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates. Papers, record 25758928. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25758928
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| HIV Infections | Major topic |
| Hepatitis C | Major topic |
| Opiate Substitution Treatment | Major topic |
| Prisons | Major topic |
| Substance Abuse, Intravenous | Major topic |
| Cross-Sectional Studies | |
| Germany | |
| Humans | |
| Prevalence | |
| Prisoners | |
| Risk Factors |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37055763 | HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice. | Harm Reduct J | 2023 | https://conductscience.org/library/papers/37055763 | PubMed |
| 36986354 | Challenges Facing Viral Hepatitis C Elimination in Lebanon. | Pathogens | 2023 | https://conductscience.org/library/papers/36986354 | PubMed |
| 36736343 | [Strategietreffen: Virushepatitis in Deutschland eliminieren]. | Z Gastroenterol | 2023 | https://conductscience.org/library/papers/36736343 | PubMed |
| 34823636 | HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019. | Euro Surveill | 2021 | https://conductscience.org/library/papers/34823636 | PubMed |
| 34136654 | Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal. | Health Sci Rep | 2021 | https://conductscience.org/library/papers/34136654 | PubMed |
| 33014960 | Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review. | Front Public Health | 2020 | https://conductscience.org/library/papers/33014960 | PubMed |
| 32903474 | Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/32903474 | PubMed |
| 32446130 | A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System. | Int J Drug Policy | 2020 | https://conductscience.org/library/papers/32446130 | PubMed |
| 32156295 | Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach. | Subst Abuse Treat Prev Policy | 2020 | https://conductscience.org/library/papers/32156295 | PubMed |
| 32150561 | The epidemiology of Hepatitis B, C and D in Germany: A scoping review. | PLoS One | 2020 | https://conductscience.org/library/papers/32150561 | PubMed |
| 30642429 | Medicine in the Penal System. | Dtsch Arztebl Int | 2018 | https://conductscience.org/library/papers/30642429 | PubMed |
| 30621658 | Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe. | BMC Public Health | 2019 | https://conductscience.org/library/papers/30621658 | PubMed |
| 29065873 | High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany. | BMC Public Health | 2017 | https://conductscience.org/library/papers/29065873 | PubMed |
| 27595567 | High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14). | BMC Public Health | 2016 | https://conductscience.org/library/papers/27595567 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25758928
GET https://conductscience.org/api/papers/v1/25758928/authors